EUVIMEDEUVIMED entdecken
Multizentrische Studie

Spanish heart transplant registry. 37th official report of the Heart Failure Association of the Spanish Society of Cardiology

Francisco González-Vílchez, Raquel López-Vilella, Manuel Gómez-Bueno, María G Crespo-Leiro, Manuel Cobo-Belaustegui, Manuel Crespín-Crespín, Carlos Ortiz-Bautista, Andrea Severo-Sánchez, Laura Triguero-Llonch, Elena García-Romero, collaborators from the Spanish transplant teams

Revista Española de Cardiología (English Edition) · 2026-11 · 79 (11) · 943-952

DOI: 10.1016/j.rec.2026.06.018 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2026-11. Verfasst von Francisco González-Vílchez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain; Instituto de Investigación Valdecilla (IDIVAL), S…. Hauptthemen laut MEDLINE: Heart Transplantation, Registries, Heart Failure, Societies, Medical. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Sociedad Española de Cardiología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: The Spanish Heart Transplant Registry is updated annually with data on all heart transplants (HTs) performed in Spain. This report includes data through 2025. In particular, it analyzes the main characteristics of HTs performed over the past decade (2016-2025). METHODS: We performed a descriptive analysis of recipient and donor characteristics, surgical procedures, and follow-up events, as well as their temporal trends since 2016. Data were collected prospectively using a standardized electronic data collection form. RESULTS: In 2025, 390 HTs were performed, the highest annual number recorded in the registry, with 7% performed in pediatric recipients. Since 2016, significant trends have been observed toward lower rates of respiratory disease, previous cardiac surgery, mechanical ventilation, and serum bilirubin levels before HT, together with increased use of extracorporeal membrane oxygenation as pretransplant support. Donors were younger, and ischemic times were shorter. The use of controlled donation after circulatory death increased markedly, accounting for 35% of all HTs performed in 2025. Survival improved (85.5% at 1 year among patients transplanted in 2022-2024), and early mortality (within 30 days) declined to 7.5% in 2025 despite a significant increase in the incidence of severe primary graft dysfunction. CONCLUSIONS: HT activity has increased over the past 5 years, largely driven by the growing use of controlled donation after circulatory death. The improvements in early and mid-term survival are confirmed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationRegistriesHeart FailureSocieties, MedicalCardiologyHumansSpainFemaleMaleAdultChildMiddle AgedTissue DonorsSurvival RateChild, PreschoolAdolescentInfantIncidenceProspective Studies

Stichwörter der Autor:innen

Análisis de supervivenciaHeart transplantRegistroRegistrySurvival analysisTrasplante cardiaco

Autor:innen und Institutionen

  • Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain; Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain; Departamento de Medicina y Psiquiatría, Universidad d…
  • Servicio de Cardiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Departamento de Cardiología, Hospital Universitario Clínica Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia Arana (IDIPHISA), Majadahonda, Madrid,…
  • Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain; Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Universidade da Coruña (UDC), A Coruña, Spain; Instituto de I…
  • Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
  • Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain.

Förderung

  • Sociedad Española de Cardiología

Zitieren

APA

González-Vílchez, F., López-Vilella, R., Gómez-Bueno, M., Crespo-Leiro, M. G., Cobo-Belaustegui, M., Crespín-Crespín, M., Ortiz-Bautista, C., Severo-Sánchez, A., Triguero-Llonch, L., García-Romero, E., & collaborators from the Spanish transplant teams (2026). Spanish heart transplant registry. 37th official report of the Heart Failure Association of the Spanish Society of Cardiology. Revista Española de Cardiología (English Edition), 79(11), 943-952. https://doi.org/10.1016/j.rec.2026.06.018

Vancouver

González-Vílchez F, López-Vilella R, Gómez-Bueno M, Crespo-Leiro MG, Cobo-Belaustegui M, Crespín-Crespín M, et al. Spanish heart transplant registry. 37th official report of the Heart Failure Association of the Spanish Society of Cardiology. Revista Española de Cardiología (English Edition). 2026;79(11):943-952. doi:10.1016/j.rec.2026.06.018

BibTeX
@article{GonzlezVlchez2026,
  author = {González-Vílchez, Francisco and López-Vilella, Raquel and Gómez-Bueno, Manuel and Crespo-Leiro, María G and Cobo-Belaustegui, Manuel and Crespín-Crespín, Manuel and Ortiz-Bautista, Carlos and Severo-Sánchez, Andrea and Triguero-Llonch, Laura and García-Romero, Elena and collaborators from the Spanish transplant teams, collaborators from the Spanish transplant teams},
  title = {Spanish heart transplant registry. 37th official report of the Heart Failure Association of the Spanish Society of Cardiology},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2026},
  volume = {79},
  number = {11},
  pages = {943--952},
  doi = {10.1016/j.rec.2026.06.018}
}
Kostenlos starten →